Vaccine Safety & Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

  • Usage and awareness in public
  • Anaphylaxis
  • Vaccine safety and quality
  • Anaphylactic hypersensitivity
  • Safe immunization schedules
  • Quality control and assurance of vaccines
  • Safety and efficacy of attenuated vaccine
  • Biomarkers for vaccine safety and efficacy

Related Conference of Vaccine Safety & Efficacy

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA

Vaccine Safety & Efficacy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in